Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Genetic Epidemiology|May 24, 2014
Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancerStacey J Winham, Sebastian M Armasu, Mine S Cicek, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|November 22, 2019
The impact of sample processing on inflammatory markers in serum: Lessons learnedAlexander Y Pan, Euijung Ryu, Jennifer R Geske, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer riskNora L Nock, Xin Liu, Mine S Cicek, et al.
Frontiers in Genetics|June 26, 2020
Impact of Diverse Data Sources on Computational PhenotypingLiwei Wang, Janet E Olson, Suzette J Bielinski, et al.
Frontiers in Public Health|March 3, 2020
Characteristics Associated With Recruitment and Re-contact in Mayo Clinic BiobankMatthew A Hathcock, Christine Kirt, Euijung Ryu, et al.
The Application of Clinical Genetics|December 1, 2018
Association of mitochondrial DNA copy number with self-rated health statusPaul Y Takahashi, Gregory D Jenkins, Benjamin P Welkie, et al.
Human Molecular Genetics|January 26, 2006
Podocalyxin variants and risk of prostate cancer and tumor aggressivenessGraham Casey, Phillippa J Neville, Xin Liu, et al.
BMC Medical Genomics|February 1, 2014
Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancerDevin C Koestler, Prabhakar Chalise, Mine S Cicek, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancerJulie M Cunningham, Scott J Hebbring, Shannon K McDonnell, et al.
Pageof 5